Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease.

Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2021 08; 148(2):574-584.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.